Shengyong Yang

Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models

Chunlei Guo, Yanan Chen, Wenjuan Gao et al. · Theranostics · 2017 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17

Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer stemness activity against non-small-cell lung cancer

Xin Wang, Chenhua Yu, Cheng Wang et al. · European Journal of Medicinal Chemistry · 2019 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +15

Discovery of the Novel Potent and Selective FLT3 Inhibitor 1-{5-[7-(3- Morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-<i>p</i>-tolylurea and Its Anti-Acute Myeloid Leukemia (AML) Activities <i>in Vitro</i> and <i>in Vivo</i>

Weiwei Li, Xiaoyan Wang, Renlin Zheng et al. · Journal of Medicinal Chemistry · 2012 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis

Zhi Huang, Borui Zhao, Zhongxiang Qin et al. · European Journal of Medicinal Chemistry · 2019 · 33 citations · Full text

Medicine, Oncology, Pharmacology +14

SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML

Shuang Ma, Lingling Yang, Ting Niu et al. · Scientific Reports · 2015 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17